We found the co-expression of TFPI and GPC3 on the surface of CLL cells and co-IP confirmed the binding between the two proteins, which is consistent with previous studies on the hepatocellular carcinoma cell line HepG233 and hematopoietic stem cells20. This evidence concerns the gene TFPI and B-cell chronic lymphocytic leukemia.